Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29272737 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL31206823 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL31207180 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL14939300 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL20599796 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL29049270 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL28628618 | 0.88 | SLC34A1 (0.39) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL31206872 | 0.88 | — | — | |
| Phosphoric Acid SCHEMBL25395731 | 0.86 | — | — | |
| Phosphoric Acid SCHEMBL21951285 | 0.86 | SLC34A1 (0.46) | SLC34A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260142188-A1 | ANODE MATERIAL AND BATTERY | BTR NEW MATERIAL GROUP CO., LTD. (CN) | 2026-05-21 | — | — | US | claimed |
| EP-4648131-A2 | MATRIX, ANODE MATERIAL, AND SECONDARY BATTERY | BTR New Material Group Co., Ltd. (CN) | 2025-11-12 | — | — | EP | claimed |
| US-20250333310-A1 | MATRIX, ANODE MATERIAL, AND SECONDARY BATTERY | BTR NEW MATERIAL GROUP CO., LTD. (CN) | 2025-10-30 | — | — | US | claimed |
| EP-4589680-A2 | ANODE MATERIAL, ANODE SHEET, AND SECONDARY BATTERY | BTR New Material Group Co., Ltd. (CN) | 2025-07-23 | — | — | EP | claimed |
| CN-119843365-A | Tantalum phosphate nonlinear optical crystal, preparation method and application thereof | 中国科学院理化技术研究所 | 2025-04-18 | — | — | CN | claimed |
| US-20250046797-A1 | Coated Single Crystalline Metal Oxide Materials and Method for Producing The Same | Action Battery Technologies, Inc. | 2025-02-06 | — | — | US | claimed |
| CN-119108525-A | Negative electrode material, negative electrode sheet, and secondary battery | 贝特瑞新材料集团股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-119092692-A | Negative electrode material, negative electrode sheet, and secondary battery | 贝特瑞新材料集团股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-119092693-A | Matrix, negative electrode material, and secondary battery | 贝特瑞新材料集团股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-119050328-A | Negative electrode material, negative electrode plate and battery | 贝特瑞新材料集团股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| US-6897027-B2 | Method for desalting nucleic acids | DECODE GENETICS EHF. (IS) | 2005-05-24 | — | — | US | claimed |
| EP-0384766-B1 | Process of preparing linearly-extended polyalkylenepolyamines | DOW CHEMICAL CO (US) | 1994-07-06 | — | — | EP | claimed |
| EP-0375355-B1 | Process for the catalytic reforming of alkylene amines to linearly-extended polyalkylene polyamines | DOW CHEMICAL CO (US) | 1994-02-02 | — | — | EP | claimed |
| US-5011999-A | Amination of difunctional aliphatic alcohols with amines; catalyst of niobium or tantalum phosphates, group 5 oxides; efficiency | THE DOW CHEMICAL COMPANY (US) | 1991-04-30 | — | — | US | claimed |
| EP-0384766-A2 | Process of preparing linearly-extended polyalkylenepolyamines | THE DOW CHEMICAL COMPANY (US) | 1990-08-29 | — | — | EP | claimed |
| EP-0375355-A2 | Process for the catalytic reforming of alkylene amines to linearly-extended polyalkylene polyamines | THE DOW CHEMICAL COMPANY (US) | 1990-06-27 | — | — | EP | claimed |
| EP-0170383-B1 | IMPROVED AROMATIC CARBOXYLIC ANHYDRIDE CATALYSTS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1989-07-19 | — | — | EP | claimed |
| US-4791092-A | SEQUENTIAL DEPOSITION AND CALCINING OF A TANTALUM COMPOUND AND A VANADIUM COMPOUND ON TITANIUM DIOXIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1988-12-13 | — | — | US | claimed |
| US-4582911-A | VANADIUM AND TANTALUM OXIDES ON TITANIUM DIOXIDE SUPPORT | EXXON RESEARCH & ENGINEERING CO. (US) | 1986-04-15 | — | — | US | claimed |
| EP-0170383-A1 | Improved aromatic carboxylic anhydride catalysts | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-02-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260142188-A1 | ANODE MATERIAL AND BATTERY | CACNA2D4, CACNA2D1, CACNA2D2 | SLC34A1 898/4885LMNA 913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.